Role of MicroRNAs as post transcription regulators of matrix metalloproteinases and their association in tuberculous meningitis

• Published in: Tuberculosis (Edinburgh, Scotland) Scotland), 2024-05, Vol.146, p.102501-102501, Article 102501
• Main Authors: Aggarwal, Apoorva, Singla, Neeraj, Konar, Monidipa, Kaur, Maninder, Sharma, Kusum, Jain, Kajal, Modi, Manish, Sharma, Sadhna
• Format: Article
• Language: English
• Subjects: Cerebrospinal fluid; Humans; Matrix metalloproteinase 2; Matrix Metalloproteinase 2 - genetics; Matrix metalloproteinase 3; Matrix Metalloproteinase 3 - genetics; MicroRNAs; Mycobacterium tuberculosis - genetics; Mycobacterium tuberculosis - metabolism; Neuroinflammatory Diseases; Tuberculosis, Meningeal - genetics; Tuberculous meningitis
• ISSN: 1472-9792; 1873-281X
• DOI: 10.1016/j.tube.2024.102501

Matrix metalloproteinases (MMPs) have a role in driving neuroinflammation in infectious as well as non-infectious diseases; however, recent reports have potentiated the role of microRNAs in regulating MMPs at post-transcriptional levels, leading to dysregulation of crucial MMP functions like tissue remodelling, blood brain barrier integrity, etc. In present study, microRNAs regulating MMPs (MMP2 and MMP3) were selected from database search followed by literature support. Expression of these microRNAs i.e., hsa-miR-495-3p, hsa-miR-132-3p and hsa-miR-21-5p was assessed by RT-PCR and the protein levels of MMPs were assessed by ELISA in the cerebrospinal fluid (CSF) of tuberculous meningitis (TBM) patients, healthy controls (HC) and non-infectious neuroinflammatory disease (NID) patients. The expression of hsa-miR-495-3p and hsa-miR-132-3p showed downregulation in TBM while hsa-miR-21-5p was overexpressed as compared to healthy controls. Moreover, MMP levels were found to be deranged with a significant increase in MMP3 levels in the TBM and NID patients compared to HC group. These observations highlight dysregulated microRNAs (hsa-miR-495-3p, hsa-miR-21-5p and hsa-miR-132-3p) levels might impair the levels of MMPs (MMP2 and MMP3) leading to neuroinflammation in TBM and NID population. These findings can further be applied to target these microRNAs for developing newer treatment modalities for better complication management. [Display omitted]